JP2010535818A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010535818A5 JP2010535818A5 JP2010520379A JP2010520379A JP2010535818A5 JP 2010535818 A5 JP2010535818 A5 JP 2010535818A5 JP 2010520379 A JP2010520379 A JP 2010520379A JP 2010520379 A JP2010520379 A JP 2010520379A JP 2010535818 A5 JP2010535818 A5 JP 2010535818A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- amino acid
- pharmaceutical composition
- composition according
- acid residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 125000000539 amino acid group Chemical group 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 8
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 102000012336 Cholesterol Ester Transfer Proteins Human genes 0.000 claims 4
- 108010061846 Cholesterol Ester Transfer Proteins Proteins 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 201000001320 Atherosclerosis Diseases 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0125807A AT505574B1 (de) | 2007-08-10 | 2007-08-10 | Mimotope zur behandlung von atherosklerose |
| PCT/AT2008/000281 WO2009021254A1 (en) | 2007-08-10 | 2008-08-08 | Treatment of atherosclerosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013198877A Division JP2014040438A (ja) | 2007-08-10 | 2013-09-25 | アテローム性動脈硬化の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010535818A JP2010535818A (ja) | 2010-11-25 |
| JP2010535818A5 true JP2010535818A5 (enExample) | 2011-09-22 |
Family
ID=39865273
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010520379A Pending JP2010535818A (ja) | 2007-08-10 | 2008-08-08 | アテローム性動脈硬化の治療 |
| JP2013198877A Pending JP2014040438A (ja) | 2007-08-10 | 2013-09-25 | アテローム性動脈硬化の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013198877A Pending JP2014040438A (ja) | 2007-08-10 | 2013-09-25 | アテローム性動脈硬化の治療 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8618046B2 (enExample) |
| EP (1) | EP2190451B1 (enExample) |
| JP (2) | JP2010535818A (enExample) |
| KR (1) | KR20100080507A (enExample) |
| CN (1) | CN101835483B (enExample) |
| AT (1) | AT505574B1 (enExample) |
| AU (1) | AU2008286667B2 (enExample) |
| CA (1) | CA2695988A1 (enExample) |
| CY (1) | CY1114760T1 (enExample) |
| DK (1) | DK2190451T3 (enExample) |
| ES (1) | ES2439703T3 (enExample) |
| HR (1) | HRP20131229T1 (enExample) |
| PL (1) | PL2190451T3 (enExample) |
| PT (1) | PT2190451E (enExample) |
| SI (1) | SI2190451T1 (enExample) |
| TW (1) | TWI442933B (enExample) |
| WO (1) | WO2009021254A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT506535B1 (de) * | 2008-02-22 | 2010-04-15 | Affiris Forschungs & Entwicklungs Gmbh | Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden |
| EP2532359A1 (en) | 2011-06-10 | 2012-12-12 | Affiris AG | CETP fragments |
| CN105849323A (zh) | 2013-10-28 | 2016-08-10 | 多茨设备公司 | 过敏原检测 |
| CN105596811A (zh) * | 2015-11-10 | 2016-05-25 | 王冬梅 | 主治动脉粥样硬化的中药组合物及制法 |
| CN110366425A (zh) * | 2016-12-15 | 2019-10-22 | 泰伦基国际有限公司 | 一种预防动脉粥样硬化及其并发症的方法 |
| WO2019020480A1 (en) * | 2017-07-24 | 2019-01-31 | INSERM (Institut National de la Santé et de la Recherche Médicale) | ANTIBODIES AND PEPTIDES FOR TREATING HCMV RELATED DISEASES |
| CN117244043B (zh) * | 2023-11-02 | 2024-09-20 | 徐州医科大学附属医院 | 破伤风类毒素在治疗血管内皮细胞损伤中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410022B1 (en) * | 1995-05-01 | 2002-06-25 | Avant Immunotherapeutics, Inc. | Modulation of cholesteryl ester transfer protein (CETP) activity |
| AT500835B1 (de) * | 2004-09-13 | 2007-12-15 | Affiris Forschungs & Entwicklungs Gmbh | Cholinestertransport-protein-mimotop als atherosklerose-medikament |
| US20060276400A1 (en) | 2005-06-06 | 2006-12-07 | Hedy Adari | Modulation of cholesteryl ester transfer protein (CETP) activity |
| KR20080082628A (ko) * | 2005-11-10 | 2008-09-11 | 리셉터 바이오로직스 인크 | 수용체 및 리간드 이소형태의 제조 방법 |
-
2007
- 2007-08-10 AT AT0125807A patent/AT505574B1/de not_active IP Right Cessation
-
2008
- 2008-08-08 PL PL08782809T patent/PL2190451T3/pl unknown
- 2008-08-08 EP EP08782809.1A patent/EP2190451B1/en not_active Not-in-force
- 2008-08-08 JP JP2010520379A patent/JP2010535818A/ja active Pending
- 2008-08-08 US US12/673,081 patent/US8618046B2/en not_active Expired - Fee Related
- 2008-08-08 ES ES08782809.1T patent/ES2439703T3/es active Active
- 2008-08-08 KR KR1020107005287A patent/KR20100080507A/ko not_active Ceased
- 2008-08-08 DK DK08782809.1T patent/DK2190451T3/da active
- 2008-08-08 CN CN2008801113067A patent/CN101835483B/zh not_active Expired - Fee Related
- 2008-08-08 SI SI200831094T patent/SI2190451T1/sl unknown
- 2008-08-08 TW TW097130215A patent/TWI442933B/zh active
- 2008-08-08 HR HRP20131229AT patent/HRP20131229T1/hr unknown
- 2008-08-08 AU AU2008286667A patent/AU2008286667B2/en not_active Ceased
- 2008-08-08 WO PCT/AT2008/000281 patent/WO2009021254A1/en not_active Ceased
- 2008-08-08 PT PT87828091T patent/PT2190451E/pt unknown
- 2008-08-08 CA CA2695988A patent/CA2695988A1/en not_active Abandoned
-
2013
- 2013-09-25 JP JP2013198877A patent/JP2014040438A/ja active Pending
- 2013-11-21 US US14/086,159 patent/US20140179900A1/en not_active Abandoned
-
2014
- 2014-01-16 CY CY20141100039T patent/CY1114760T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010535818A5 (enExample) | ||
| JP2025102780A (ja) | 神経ペプチドｙ受容体の調節因子としての環状ペプチドチロシンチロシン化合物 | |
| RU2011100125A (ru) | Соединения для лечения амилоидозов | |
| JP2016512213A5 (enExample) | ||
| EP3533461A3 (en) | Prame derived peptides and immunogenic compositions comprising these | |
| WO2006121656A3 (en) | Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease | |
| JP2018515088A5 (enExample) | ||
| JP2020524675A5 (enExample) | ||
| RU2011100126A (ru) | Применение мимотопов для лечения бетта-амилоидозов | |
| AU2015298263B2 (en) | ApoE mimetic peptides and higher potency to clear plasma cholesterol | |
| PE20231841A1 (es) | Coagonistas de los receptores glp-1 y gip adecuados para el suministro oral | |
| WO2009034134A3 (en) | Use of natriuretic peptides for treating angioedema syndromes | |
| IL196532A0 (en) | Immunological methods and compositions for the treatment of alzheimer's disease | |
| JP2014503172A5 (enExample) | ||
| WO2011149964A3 (en) | Methods for treating or preventing vascular graft failure | |
| US20160015788A1 (en) | Treatment of neurological diseases | |
| JP2008530975A5 (enExample) | ||
| CZ100693A3 (en) | Non-peptidic antagonists of bembesin | |
| PE20231842A1 (es) | Coagonistas de los receptores de glp-1 y gip | |
| JP2009527510A5 (enExample) | ||
| MX2011004176A (es) | Peptido-epitope rab6kifl/kif20a y vacunas que contienen el mismo. | |
| JP2008521837A5 (enExample) | ||
| EP3556857A3 (en) | Cdc45l peptides and vaccines including the same | |
| CN118510545A (zh) | 用于治疗神经退行性疾病的肽-药物缀合物 | |
| DE60139952D1 (de) | Immunogene glycopeptide. screening- und herstellungsverfahren sowie verwendungen |